A $20 Billion Industry

The growing Biologic Infusion market
The Biologic Infusion Market is estimated at $20BN+

  • Growing drug pipeline: Over 30+ target market drugs in stage 3 of clinical trials
  • Increased patient diagnosis: Advancement in medical understanding and diagnosis of targeted conditions (i.e. MS, arthritis, etc.) continues to expand market opportunity
  • Effective treatments leading to longer patient life: Proven success of biologics as the most effective treatment option extends patient’s quality of life and further expands market

Specialty Treatments and Therapies

Reach a diversified customer base.
Ability to service specialty patients across several medical therapies, not just one segment of patients:

  • Rheumatology
  • Neurology
  • Immunology
  • Gastrology

A Safe Investment That’s Recession Resistant

  • Our care is a priority.
    Healthcare is considered highly recession-proof as patients will always need care and prioritize it above other needs.
  • Limited Competition
    Our model is unique. Market is emerging, fragmented, with no single competitor with dominant market share.
  • Low Capex
    Opening new sites requires minimal capital investment
  • Strong Site Financials
    Highly profitable site economics.


We have multiple centers in the Tampa Bay Area, all conveniently located near major hospitals with plenty of parking.


Hours (by appointment):

Monday – Thursday 7am-8pm
Friday  7am-5pm
Saturday 8am-6pm


Hours (by appointment):

Monday – Thursday 7am-8pm
Friday  7am-5pm
Saturday 8am-6pm